+1 (704) 266-3234

Global Pharmacovigilance And Drug Safety Software Market Size, Status And Forecast 2021-2027

Published on: Jul 2021 | From USD $2900 | Published By: QY RESEARCH | Number Of Pages: 107

Market Analysis and Insights: Global Pharmacovigilance and Drug Safety Software Market
The global Pharmacovigilance and Drug Safety Software market size is projected to reach US$ 171.5 million by 2027, from US$ 116.7 million in 2020, at a CAGR of 5.2% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Pharmacovigilance and Drug Safety Software market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Pharmacovigilance and Drug Safety Software market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Pharmacovigilance and Drug Safety Software market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Pharmacovigilance and Drug Safety Software market.

Global Pharmacovigilance and Drug Safety Software Scope and Market Size
Pharmacovigilance and Drug Safety Software market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Pharmacovigilance and Drug Safety Software market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Adverse Event Reporting Software
Drug Safety Audits Software
Issue Tracking Software
Fully Integrated Software

Segment by Application
Pharma and Biotech Companies
Contract Research Organizations (CROs)
Business Process Outsourcing (BPO) Firms
Pharmacovigilance Service Providers
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
AB Cube
Sparta Systems, Inc.
Oracle Corporation
EXTEDO GmbH
Ennov Solutions, Inc.
ArisGlobal
Oracle Corporation
United BioSource Corporation
Online Business Applications, Inc.
UMBRA Global LLC

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pharmacovigilance and Drug Safety Software Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Adverse Event Reporting Software
1.2.3 Drug Safety Audits Software
1.2.4 Issue Tracking Software
1.2.5 Fully Integrated Software
1.3 Market by Application
1.3.1 Global Pharmacovigilance and Drug Safety Software Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Pharma and Biotech Companies
1.3.3 Contract Research Organizations (CROs)
1.3.4 Business Process Outsourcing (BPO) Firms
1.3.5 Pharmacovigilance Service Providers
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Pharmacovigilance and Drug Safety Software Market Perspective (2016-2027)
2.2 Pharmacovigilance and Drug Safety Software Growth Trends by Regions
2.2.1 Pharmacovigilance and Drug Safety Software Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Pharmacovigilance and Drug Safety Software Historic Market Share by Regions (2016-2021)
2.2.3 Pharmacovigilance and Drug Safety Software Forecasted Market Size by Regions (2022-2027)
2.3 Pharmacovigilance and Drug Safety Software Industry Dynamic
2.3.1 Pharmacovigilance and Drug Safety Software Market Trends
2.3.2 Pharmacovigilance and Drug Safety Software Market Drivers
2.3.3 Pharmacovigilance and Drug Safety Software Market Challenges
2.3.4 Pharmacovigilance and Drug Safety Software Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Pharmacovigilance and Drug Safety Software Players by Revenue
3.1.1 Global Top Pharmacovigilance and Drug Safety Software Players by Revenue (2016-2021)
3.1.2 Global Pharmacovigilance and Drug Safety Software Revenue Market Share by Players (2016-2021)
3.2 Global Pharmacovigilance and Drug Safety Software Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Pharmacovigilance and Drug Safety Software Revenue
3.4 Global Pharmacovigilance and Drug Safety Software Market Concentration Ratio
3.4.1 Global Pharmacovigilance and Drug Safety Software Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pharmacovigilance and Drug Safety Software Revenue in 2020
3.5 Pharmacovigilance and Drug Safety Software Key Players Head office and Area Served
3.6 Key Players Pharmacovigilance and Drug Safety Software Product Solution and Service
3.7 Date of Enter into Pharmacovigilance and Drug Safety Software Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Pharmacovigilance and Drug Safety Software Breakdown Data by Type
4.1 Global Pharmacovigilance and Drug Safety Software Historic Market Size by Type (2016-2021)
4.2 Global Pharmacovigilance and Drug Safety Software Forecasted Market Size by Type (2022-2027)

5 Pharmacovigilance and Drug Safety Software Breakdown Data by Application
5.1 Global Pharmacovigilance and Drug Safety Software Historic Market Size by Application (2016-2021)
5.2 Global Pharmacovigilance and Drug Safety Software Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Pharmacovigilance and Drug Safety Software Market Size (2016-2027)
6.2 North America Pharmacovigilance and Drug Safety Software Market Size by Type
6.2.1 North America Pharmacovigilance and Drug Safety Software Market Size by Type (2016-2021)
6.2.2 North America Pharmacovigilance and Drug Safety Software Market Size by Type (2022-2027)
6.2.3 North America Pharmacovigilance and Drug Safety Software Market Size by Type (2016-2027)
6.3 North America Pharmacovigilance and Drug Safety Software Market Size by Application
6.3.1 North America Pharmacovigilance and Drug Safety Software Market Size by Application (2016-2021)
6.3.2 North America Pharmacovigilance and Drug Safety Software Market Size by Application (2022-2027)
6.3.3 North America Pharmacovigilance and Drug Safety Software Market Size by Application (2016-2027)
6.4 North America Pharmacovigilance and Drug Safety Software Market Size by Country
6.4.1 North America Pharmacovigilance and Drug Safety Software Market Size by Country (2016-2021)
6.4.2 North America Pharmacovigilance and Drug Safety Software Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Pharmacovigilance and Drug Safety Software Market Size (2016-2027)
7.2 Europe Pharmacovigilance and Drug Safety Software Market Size by Type
7.2.1 Europe Pharmacovigilance and Drug Safety Software Market Size by Type (2016-2021)
7.2.2 Europe Pharmacovigilance and Drug Safety Software Market Size by Type (2022-2027)
7.2.3 Europe Pharmacovigilance and Drug Safety Software Market Size by Type (2016-2027)
7.3 Europe Pharmacovigilance and Drug Safety Software Market Size by Application
7.3.1 Europe Pharmacovigilance and Drug Safety Software Market Size by Application (2016-2021)
7.3.2 Europe Pharmacovigilance and Drug Safety Software Market Size by Application (2022-2027)
7.3.3 Europe Pharmacovigilance and Drug Safety Software Market Size by Application (2016-2027)
7.4 Europe Pharmacovigilance and Drug Safety Software Market Size by Country
7.4.1 Europe Pharmacovigilance and Drug Safety Software Market Size by Country (2016-2021)
7.4.2 Europe Pharmacovigilance and Drug Safety Software Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Pharmacovigilance and Drug Safety Software Market Size (2016-2027)
8.2 Asia-Pacific Pharmacovigilance and Drug Safety Software Market Size by Type
8.2.1 Asia-Pacific Pharmacovigilance and Drug Safety Software Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Pharmacovigilance and Drug Safety Software Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Pharmacovigilance and Drug Safety Software Market Size by Type (2016-2027)
8.3 Asia-Pacific Pharmacovigilance and Drug Safety Software Market Size by Application
8.3.1 Asia-Pacific Pharmacovigilance and Drug Safety Software Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Pharmacovigilance and Drug Safety Software Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Pharmacovigilance and Drug Safety Software Market Size by Application (2016-2027)
8.4 Asia-Pacific Pharmacovigilance and Drug Safety Software Market Size by Region
8.4.1 Asia-Pacific Pharmacovigilance and Drug Safety Software Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Pharmacovigilance and Drug Safety Software Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Pharmacovigilance and Drug Safety Software Market Size (2016-2027)
9.2 Latin America Pharmacovigilance and Drug Safety Software Market Size by Type
9.2.1 Latin America Pharmacovigilance and Drug Safety Software Market Size by Type (2016-2021)
9.2.2 Latin America Pharmacovigilance and Drug Safety Software Market Size by Type (2022-2027)
9.2.3 Latin America Pharmacovigilance and Drug Safety Software Market Size by Type (2016-2027)
9.3 Latin America Pharmacovigilance and Drug Safety Software Market Size by Application
9.3.1 Latin America Pharmacovigilance and Drug Safety Software Market Size by Application (2016-2021)
9.3.2 Latin America Pharmacovigilance and Drug Safety Software Market Size by Application (2022-2027)
9.3.3 Latin America Pharmacovigilance and Drug Safety Software Market Size by Application (2016-2027)
9.4 Latin America Pharmacovigilance and Drug Safety Software Market Size by Country
9.4.1 Latin America Pharmacovigilance and Drug Safety Software Market Size by Country (2016-2021)
9.4.2 Latin America Pharmacovigilance and Drug Safety Software Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Pharmacovigilance and Drug Safety Software Market Size (2016-2027)
10.2 Middle East & Africa Pharmacovigilance and Drug Safety Software Market Size by Type
10.2.1 Middle East & Africa Pharmacovigilance and Drug Safety Software Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Pharmacovigilance and Drug Safety Software Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Pharmacovigilance and Drug Safety Software Market Size by Type (2016-2027)
10.3 Middle East & Africa Pharmacovigilance and Drug Safety Software Market Size by Application
10.3.1 Middle East & Africa Pharmacovigilance and Drug Safety Software Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Pharmacovigilance and Drug Safety Software Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Pharmacovigilance and Drug Safety Software Market Size by Application (2016-2027)
10.4 Middle East & Africa Pharmacovigilance and Drug Safety Software Market Size by Country
10.4.1 Middle East & Africa Pharmacovigilance and Drug Safety Software Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Pharmacovigilance and Drug Safety Software Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 AB Cube
11.1.1 AB Cube Company Details
11.1.2 AB Cube Business Overview
11.1.3 AB Cube Pharmacovigilance and Drug Safety Software Introduction
11.1.4 AB Cube Revenue in Pharmacovigilance and Drug Safety Software Business (2016-2021)
11.1.5 AB Cube Recent Development
11.2 Sparta Systems, Inc.
11.2.1 Sparta Systems, Inc. Company Details
11.2.2 Sparta Systems, Inc. Business Overview
11.2.3 Sparta Systems, Inc. Pharmacovigilance and Drug Safety Software Introduction
11.2.4 Sparta Systems, Inc. Revenue in Pharmacovigilance and Drug Safety Software Business (2016-2021)
11.2.5 Sparta Systems, Inc. Recent Development
11.3 Oracle Corporation
11.3.1 Oracle Corporation Company Details
11.3.2 Oracle Corporation Business Overview
11.3.3 Oracle Corporation Pharmacovigilance and Drug Safety Software Introduction
11.3.4 Oracle Corporation Revenue in Pharmacovigilance and Drug Safety Software Business (2016-2021)
11.3.5 Oracle Corporation Recent Development
11.4 EXTEDO GmbH
11.4.1 EXTEDO GmbH Company Details
11.4.2 EXTEDO GmbH Business Overview
11.4.3 EXTEDO GmbH Pharmacovigilance and Drug Safety Software Introduction
11.4.4 EXTEDO GmbH Revenue in Pharmacovigilance and Drug Safety Software Business (2016-2021)
11.4.5 EXTEDO GmbH Recent Development
11.5 Ennov Solutions, Inc.
11.5.1 Ennov Solutions, Inc. Company Details
11.5.2 Ennov Solutions, Inc. Business Overview
11.5.3 Ennov Solutions, Inc. Pharmacovigilance and Drug Safety Software Introduction
11.5.4 Ennov Solutions, Inc. Revenue in Pharmacovigilance and Drug Safety Software Business (2016-2021)
11.5.5 Ennov Solutions, Inc. Recent Development
11.6 ArisGlobal
11.6.1 ArisGlobal Company Details
11.6.2 ArisGlobal Business Overview
11.6.3 ArisGlobal Pharmacovigilance and Drug Safety Software Introduction
11.6.4 ArisGlobal Revenue in Pharmacovigilance and Drug Safety Software Business (2016-2021)
11.6.5 ArisGlobal Recent Development
11.7 Oracle Corporation
11.7.1 Oracle Corporation Company Details
11.7.2 Oracle Corporation Business Overview
11.7.3 Oracle Corporation Pharmacovigilance and Drug Safety Software Introduction
11.7.4 Oracle Corporation Revenue in Pharmacovigilance and Drug Safety Software Business (2016-2021)
11.7.5 Oracle Corporation Recent Development
11.8 United BioSource Corporation
11.8.1 United BioSource Corporation Company Details
11.8.2 United BioSource Corporation Business Overview
11.8.3 United BioSource Corporation Pharmacovigilance and Drug Safety Software Introduction
11.8.4 United BioSource Corporation Revenue in Pharmacovigilance and Drug Safety Software Business (2016-2021)
11.8.5 United BioSource Corporation Recent Development
11.9 Online Business Applications, Inc.
11.9.1 Online Business Applications, Inc. Company Details
11.9.2 Online Business Applications, Inc. Business Overview
11.9.3 Online Business Applications, Inc. Pharmacovigilance and Drug Safety Software Introduction
11.9.4 Online Business Applications, Inc. Revenue in Pharmacovigilance and Drug Safety Software Business (2016-2021)
11.9.5 Online Business Applications, Inc. Recent Development
11.10 UMBRA Global LLC
11.10.1 UMBRA Global LLC Company Details
11.10.2 UMBRA Global LLC Business Overview
11.10.3 UMBRA Global LLC Pharmacovigilance and Drug Safety Software Introduction
11.10.4 UMBRA Global LLC Revenue in Pharmacovigilance and Drug Safety Software Business (2016-2021)
11.10.5 UMBRA Global LLC Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Pharmacovigilance and Drug Safety Software Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Adverse Event Reporting Software
Table 3. Key Players of Drug Safety Audits Software
Table 4. Key Players of Issue Tracking Software
Table 5. Key Players of Fully Integrated Software
Table 6. Global Pharmacovigilance and Drug Safety Software Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Pharmacovigilance and Drug Safety Software Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Pharmacovigilance and Drug Safety Software Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Pharmacovigilance and Drug Safety Software Market Share by Regions (2016-2021)
Table 10. Global Pharmacovigilance and Drug Safety Software Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Pharmacovigilance and Drug Safety Software Market Share by Regions (2022-2027)
Table 12. Pharmacovigilance and Drug Safety Software Market Trends
Table 13. Pharmacovigilance and Drug Safety Software Market Drivers
Table 14. Pharmacovigilance and Drug Safety Software Market Challenges
Table 15. Pharmacovigilance and Drug Safety Software Market Restraints
Table 16. Global Pharmacovigilance and Drug Safety Software Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Pharmacovigilance and Drug Safety Software Market Share by Players (2016-2021)
Table 18. Global Top Pharmacovigilance and Drug Safety Software Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pharmacovigilance and Drug Safety Software as of 2020)
Table 19. Ranking of Global Top Pharmacovigilance and Drug Safety Software Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Pharmacovigilance and Drug Safety Software Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Pharmacovigilance and Drug Safety Software Product Solution and Service
Table 23. Date of Enter into Pharmacovigilance and Drug Safety Software Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Pharmacovigilance and Drug Safety Software Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Pharmacovigilance and Drug Safety Software Revenue Market Share by Type (2016-2021)
Table 27. Global Pharmacovigilance and Drug Safety Software Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Pharmacovigilance and Drug Safety Software Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Pharmacovigilance and Drug Safety Software Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Pharmacovigilance and Drug Safety Software Revenue Market Share by Application (2016-2021)
Table 31. Global Pharmacovigilance and Drug Safety Software Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Pharmacovigilance and Drug Safety Software Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Pharmacovigilance and Drug Safety Software Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Pharmacovigilance and Drug Safety Software Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Pharmacovigilance and Drug Safety Software Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Pharmacovigilance and Drug Safety Software Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Pharmacovigilance and Drug Safety Software Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Pharmacovigilance and Drug Safety Software Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Pharmacovigilance and Drug Safety Software Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Pharmacovigilance and Drug Safety Software Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Pharmacovigilance and Drug Safety Software Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Pharmacovigilance and Drug Safety Software Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Pharmacovigilance and Drug Safety Software Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Pharmacovigilance and Drug Safety Software Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Pharmacovigilance and Drug Safety Software Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Pharmacovigilance and Drug Safety Software Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Pharmacovigilance and Drug Safety Software Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Pharmacovigilance and Drug Safety Software Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Pharmacovigilance and Drug Safety Software Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Pharmacovigilance and Drug Safety Software Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Pharmacovigilance and Drug Safety Software Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Pharmacovigilance and Drug Safety Software Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Pharmacovigilance and Drug Safety Software Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Pharmacovigilance and Drug Safety Software Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Pharmacovigilance and Drug Safety Software Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Pharmacovigilance and Drug Safety Software Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Pharmacovigilance and Drug Safety Software Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Pharmacovigilance and Drug Safety Software Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Pharmacovigilance and Drug Safety Software Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Pharmacovigilance and Drug Safety Software Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Pharmacovigilance and Drug Safety Software Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Pharmacovigilance and Drug Safety Software Market Size by Country (2022-2027) & (US$ Million)
Table 63. AB Cube Company Details
Table 64. AB Cube Business Overview
Table 65. AB Cube Pharmacovigilance and Drug Safety Software Product
Table 66. AB Cube Revenue in Pharmacovigilance and Drug Safety Software Business (2016-2021) & (US$ Million)
Table 67. AB Cube Recent Development
Table 68. Sparta Systems, Inc. Company Details
Table 69. Sparta Systems, Inc. Business Overview
Table 70. Sparta Systems, Inc. Pharmacovigilance and Drug Safety Software Product
Table 71. Sparta Systems, Inc. Revenue in Pharmacovigilance and Drug Safety Software Business (2016-2021) & (US$ Million)
Table 72. Sparta Systems, Inc. Recent Development
Table 73. Oracle Corporation Company Details
Table 74. Oracle Corporation Business Overview
Table 75. Oracle Corporation Pharmacovigilance and Drug Safety Software Product
Table 76. Oracle Corporation Revenue in Pharmacovigilance and Drug Safety Software Business (2016-2021) & (US$ Million)
Table 77. Oracle Corporation Recent Development
Table 78. EXTEDO GmbH Company Details
Table 79. EXTEDO GmbH Business Overview
Table 80. EXTEDO GmbH Pharmacovigilance and Drug Safety Software Product
Table 81. EXTEDO GmbH Revenue in Pharmacovigilance and Drug Safety Software Business (2016-2021) & (US$ Million)
Table 82. EXTEDO GmbH Recent Development
Table 83. Ennov Solutions, Inc. Company Details
Table 84. Ennov Solutions, Inc. Business Overview
Table 85. Ennov Solutions, Inc. Pharmacovigilance and Drug Safety Software Product
Table 86. Ennov Solutions, Inc. Revenue in Pharmacovigilance and Drug Safety Software Business (2016-2021) & (US$ Million)
Table 87. Ennov Solutions, Inc. Recent Development
Table 88. ArisGlobal Company Details
Table 89. ArisGlobal Business Overview
Table 90. ArisGlobal Pharmacovigilance and Drug Safety Software Product
Table 91. ArisGlobal Revenue in Pharmacovigilance and Drug Safety Software Business (2016-2021) & (US$ Million)
Table 92. ArisGlobal Recent Development
Table 93. Oracle Corporation Company Details
Table 94. Oracle Corporation Business Overview
Table 95. Oracle Corporation Pharmacovigilance and Drug Safety Software Product
Table 96. Oracle Corporation Revenue in Pharmacovigilance and Drug Safety Software Business (2016-2021) & (US$ Million)
Table 97. Oracle Corporation Recent Development
Table 98. United BioSource Corporation Company Details
Table 99. United BioSource Corporation Business Overview
Table 100. United BioSource Corporation Revenue in Pharmacovigilance and Drug Safety Software Business (2016-2021) & (US$ Million)
Table 101. United BioSource Corporation Recent Development
Table 102. Online Business Applications, Inc. Company Details
Table 103. Online Business Applications, Inc. Business Overview
Table 104. Online Business Applications, Inc. Pharmacovigilance and Drug Safety Software Product
Table 105. Online Business Applications, Inc. Revenue in Pharmacovigilance and Drug Safety Software Business (2016-2021) & (US$ Million)
Table 106. Online Business Applications, Inc. Recent Development
Table 107. UMBRA Global LLC Company Details
Table 108. UMBRA Global LLC Business Overview
Table 109. UMBRA Global LLC Pharmacovigilance and Drug Safety Software Product
Table 110. UMBRA Global LLC Revenue in Pharmacovigilance and Drug Safety Software Business (2016-2021) & (US$ Million)
Table 111. UMBRA Global LLC Recent Development
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Pharmacovigilance and Drug Safety Software Market Share by Type: 2020 VS 2027
Figure 2. Adverse Event Reporting Software Features
Figure 3. Drug Safety Audits Software Features
Figure 4. Issue Tracking Software Features
Figure 5. Fully Integrated Software Features
Figure 6. Global Pharmacovigilance and Drug Safety Software Market Share by Application: 2020 VS 2027
Figure 7. Pharma and Biotech Companies Case Studies
Figure 8. Contract Research Organizations (CROs) Case Studies
Figure 9. Business Process Outsourcing (BPO) Firms Case Studies
Figure 10. Pharmacovigilance Service Providers Case Studies
Figure 11. Others Case Studies
Figure 12. Pharmacovigilance and Drug Safety Software Report Years Considered
Figure 13. Global Pharmacovigilance and Drug Safety Software Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 14. Global Pharmacovigilance and Drug Safety Software Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Pharmacovigilance and Drug Safety Software Market Share by Regions: 2020 VS 2027
Figure 16. Global Pharmacovigilance and Drug Safety Software Market Share by Regions (2022-2027)
Figure 17. Global Pharmacovigilance and Drug Safety Software Market Share by Players in 2020
Figure 18. Global Top Pharmacovigilance and Drug Safety Software Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pharmacovigilance and Drug Safety Software as of 2020
Figure 19. The Top 10 and 5 Players Market Share by Pharmacovigilance and Drug Safety Software Revenue in 2020
Figure 20. Global Pharmacovigilance and Drug Safety Software Revenue Market Share by Type (2016-2021)
Figure 21. Global Pharmacovigilance and Drug Safety Software Revenue Market Share by Type (2022-2027)
Figure 22. North America Pharmacovigilance and Drug Safety Software Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. North America Pharmacovigilance and Drug Safety Software Market Share by Type (2016-2027)
Figure 24. North America Pharmacovigilance and Drug Safety Software Market Share by Application (2016-2027)
Figure 25. North America Pharmacovigilance and Drug Safety Software Market Share by Country (2016-2027)
Figure 26. United States Pharmacovigilance and Drug Safety Software Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Canada Pharmacovigilance and Drug Safety Software Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Pharmacovigilance and Drug Safety Software Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Pharmacovigilance and Drug Safety Software Market Share by Type (2016-2027)
Figure 30. Europe Pharmacovigilance and Drug Safety Software Market Share by Application (2016-2027)
Figure 31. Europe Pharmacovigilance and Drug Safety Software Market Share by Country (2016-2027)
Figure 32. Germany Pharmacovigilance and Drug Safety Software Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. France Pharmacovigilance and Drug Safety Software Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. U.K. Pharmacovigilance and Drug Safety Software Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Italy Pharmacovigilance and Drug Safety Software Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Russia Pharmacovigilance and Drug Safety Software Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Nordic Pharmacovigilance and Drug Safety Software Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Pharmacovigilance and Drug Safety Software Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Pharmacovigilance and Drug Safety Software Market Share by Type (2016-2027)
Figure 40. Asia-Pacific Pharmacovigilance and Drug Safety Software Market Share by Application (2016-2027)
Figure 41. Asia-Pacific Pharmacovigilance and Drug Safety Software Market Share by Region (2016-2027)
Figure 42. China Pharmacovigilance and Drug Safety Software Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Japan Pharmacovigilance and Drug Safety Software Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. South Korea Pharmacovigilance and Drug Safety Software Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Southeast Asia Pharmacovigilance and Drug Safety Software Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. India Pharmacovigilance and Drug Safety Software Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Australia Pharmacovigilance and Drug Safety Software Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Pharmacovigilance and Drug Safety Software Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Pharmacovigilance and Drug Safety Software Market Share by Type (2016-2027)
Figure 50. Latin America Pharmacovigilance and Drug Safety Software Market Share by Application (2016-2027)
Figure 51. Latin America Pharmacovigilance and Drug Safety Software Market Share by Country (2016-2027)
Figure 52. Mexico Pharmacovigilance and Drug Safety Software Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Brazil Pharmacovigilance and Drug Safety Software Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Pharmacovigilance and Drug Safety Software Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Pharmacovigilance and Drug Safety Software Market Share by Type (2016-2027)
Figure 56. Middle East & Africa Pharmacovigilance and Drug Safety Software Market Share by Application (2016-2027)
Figure 57. Middle East & Africa Pharmacovigilance and Drug Safety Software Market Share by Country (2016-2027)
Figure 58. Turkey Pharmacovigilance and Drug Safety Software Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Saudi Arabia Pharmacovigilance and Drug Safety Software Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. UAE Pharmacovigilance and Drug Safety Software Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. AB Cube Revenue Growth Rate in Pharmacovigilance and Drug Safety Software Business (2016-2021)
Figure 62. Sparta Systems, Inc. Revenue Growth Rate in Pharmacovigilance and Drug Safety Software Business (2016-2021)
Figure 63. Oracle Corporation Revenue Growth Rate in Pharmacovigilance and Drug Safety Software Business (2016-2021)
Figure 64. EXTEDO GmbH Revenue Growth Rate in Pharmacovigilance and Drug Safety Software Business (2016-2021)
Figure 65. Ennov Solutions, Inc. Revenue Growth Rate in Pharmacovigilance and Drug Safety Software Business (2016-2021)
Figure 66. ArisGlobal Revenue Growth Rate in Pharmacovigilance and Drug Safety Software Business (2016-2021)
Figure 67. Oracle Corporation Revenue Growth Rate in Pharmacovigilance and Drug Safety Software Business (2016-2021)
Figure 68. United BioSource Corporation Revenue Growth Rate in Pharmacovigilance and Drug Safety Software Business (2016-2021)
Figure 69. Online Business Applications, Inc. Revenue Growth Rate in Pharmacovigilance and Drug Safety Software Business (2016-2021)
Figure 70. UMBRA Global LLC Revenue Growth Rate in Pharmacovigilance and Drug Safety Software Business (2016-2021)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed

SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.

REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.

Please Choose License Type

USD $2900
USD $3900
USD $4900
COVID-19
Offer

WHY US?

  • Why Us In-depth database
    Our Report’s database covers almost all topics of all regions over the Globe..
  • Why Us Recognised publishing sources
    Tie ups with top publishers around the globe.
  • Why Us Customer Support
    Complete pre and post sales support.
  • Why Us Safe & Secure
    Complete secure payment process.